TissGeneSummary for RBP5 |
Gene summary |
Basic gene information | Gene symbol | RBP5 |
Gene name | retinol binding protein 5, cellular | |
Synonyms | CRBP-III|CRBP3|CRBPIII | |
Cytomap | UCSC genome browser: 12p13.31 | |
Type of gene | protein-coding | |
RefGenes | NM_031491.2, | |
Description | HRBPisocellular retinol-binding protein IIIputative cellular retinol-binding protein CRBP IIIretinol-binding protein 5retinol-binding protein 5, cellular | |
Modification date | 20141207 | |
dbXrefs | MIM : 611866 | |
HGNC : HGNC | ||
Ensembl : ENSG00000139194 | ||
HPRD : 17961 | ||
Vega : OTTHUMG00000168165 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_RBP5 | |
BioGPS: 83758 | ||
Pathway | NCI Pathway Interaction Database: RBP5 | |
KEGG: RBP5 | ||
REACTOME: RBP5 | ||
Pathway Commons: RBP5 | ||
Context | iHOP: RBP5 | |
ligand binding site mutation search in PubMed: RBP5 | ||
UCL Cancer Institute: RBP5 | ||
Assigned class in TissGDB* | C | |
Included tissue-specific gene expression resources | TiGER,GTEx | |
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | Kidney | |
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | KIRC,KIRP,KICH | |
Reference showing the relevant tissue of RBP5 | ||
Description by TissGene annotations |
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO term | PubMed ID |
Top |
TissGeneExp for RBP5 |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
KIRP | 4.369360836 | 7.069882711 | -2.700521875 | 1.94E-06 | 9.18E-06 |
LUSC | 0.150175297 | 1.43535961 | -1.285184314 | 1.24E-06 | 3.08E-06 |
COAD | 0.17706949 | 1.867223336 | -1.690153846 | 1.79E-08 | 1.49E-07 |
KICH | 1.454361336 | 6.038605336 | -4.584244 | 9.59E-14 | 1.39E-12 |
LIHC | 5.577039336 | 7.352455336 | -1.775416 | 1.95E-07 | 1.27E-06 |
HNSC | -1.834075501 | -0.809538292 | -1.024537209 | 0.00252 | 0.00752988 |
BLCA | -0.545116138 | 1.070094389 | -1.615210526 | 0.000351 | 0.003034295 |
THCA | 0.24358859 | 1.262729268 | -1.019140678 | 8.64E-05 | 0.000239112 |
Top |
TissGene-miRNA for RBP5 |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
Top |
TissGeneMut for RBP5 |
TissGeneSNV for RBP5 |
nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
- nsSNVs sorted by frequency. |
AAchange | Cancer type | # samples |
p.R81Q | SKCM | 2 |
p.Y61H | KIRP | 1 |
p.E90G | STAD | 1 |
p.V67A | BLCA | 1 |
p.Q46X | SKCM | 1 |
p.A34V | COAD | 1 |
p.E119K | SKCM | 1 |
p.A34T | UCEC | 1 |
p.P2L | UCEC | 1 |
p.T51A | UCEC | 1 |
p.R81* | UCEC | 1 |
p.D40G | SKCM | 1 |
p.F11Y | LIHC | 1 |
p.E72G | UCEC | 1 |
p.G68R | OV | 1 |
p.Q46* | SKCM | 1 |
Top |
TissGeneCNV for RBP5 |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
Top |
TissGeneFusions for RBP5 |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
Chimerdb3.0 | ChiTaRs | NA | BF871061 | RBP5-ENOX1 | chr12:7281493 | chr13:44021002 |
Top |
TissGeneNet for RBP5 |
Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
Top |
TissGeneProg for RBP5 |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Top |
TissGeneClin for RBP5 |
TissGeneDrug for RBP5 |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
TissGeneDisease for RBP5 |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
Disease ID | Disease name | # pubmeds | Source |